Excel Trust (EXL) 14.35 $EXL The Shopping Center REIT

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Excel Trust (EXL) 14.35 $EXL

The Shopping Center REIT Showdown: March Madness Continues
Brad Thomas - at Seeking Alpha - Tue Mar 17, 6:00AM CDT

ROIC: 18.55 (+0.51), RPT: 19.30 (+0.38), BX: 38.69 (unch), FRT: 149.44 (+3.04), WSR: 16.32 (+0.41), EXL: 14.35 (+0.23), DDR: 19.33 (+0.43), IRC: 10.98 (+0.25), WPG: 17.06 (+0.35), KIM: 27.74 (+0.75), EQY: 27.49 (+0.44), WRI: 37.19 (+0.81), REG: 69.90 (+2.17), RPAI: 16.34 (+0.33), UBA: 23.47 (+0.36), WHLR: 2.63 (-0.08), BRX: 27.01 (+0.64)

Excel Trust Completes Disposition of Promenade Corporate Center for $65 Million
Marketwired - Mon Mar 16, 5:37PM CDT
Excel Trust, Inc. (NYSE: EXL) announced the sale of Promenade Corporate Center in Scottsdale, Arizona for $65.0 million. The Promenade Corporate Center is comprised of two Class A office towers with 256,157 square feet of combined gross leasable area (note: sale does not include any of the surrounding retail at Scottsdale Promenade owned by Excel Trust). The Company purchased the asset in 2012 at an initial cost basis of $53.0 million and expects to realize a gain of approximately $15.1 million based on the depreciated book value of the property at the time of sale.
EXL: 14.35 (+0.23)

Better Call Saul? I'll Keep Dialing
Rubicon Associates - at Seeking Alpha - Tue Mar 10, 11:27AM CDT

IRC: 10.98 (+0.25), KIM: 27.74 (+0.75), BFS: 57.37 (+0.53), KRG: 28.87 (+0.80), REG: 69.90 (+2.17), CDR: 7.61 (+0.10), UBA: 23.47 (+0.36), FRT: 149.44 (+3.04), EXL: 14.35 (+0.23)

Excel Trust's (EXL) CEO Gary Sabin on Q4 2014 Results -- Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Feb 13, 5:00PM CST

EXL: 14.35 (+0.23)

Charlie Brown's Under The Radar $10 REIT Portfolio
Brad Thomas - at Seeking Alpha - Thu Feb 12, 6:00AM CST

LXP: 10.39 (+0.18), FPI: 10.97 (-0.01), DX: 8.49 (+0.18), CCG: 7.75 (-0.12), CTRE: 13.61 (+0.40), CSG: 7.94 (+0.13), IRC: 10.98 (+0.25), INN: 14.23 (+0.30), FCH: 11.91 (+0.51), CUZ: 10.87 (+0.35), LOAN: 3.98 (+0.08), VNQ: 87.03 (+2.13), AHH: 10.93 (-0.01), IRT: 9.50 (+0.03), MORE: 9.92 (+0.34), AHT: 10.16 (+0.27), EXL: 14.35 (+0.23), NYRT: 10.51 (+0.19), RAS: 6.65 (-0.09), SOHO: 7.73 (+0.18), BEE: 12.95 (+0.34), APTS: 10.95 (+0.26), GPT: 7.37 (+0.23), MNR: 11.32 (+0.26), WHLR: 2.63 (-0.08), ARCP: 10.09 (+0.23), LAND: 11.75 (+0.20), CORR: 7.03 (+0.25), UMH: 10.24 (+0.25)

Excel Trust guides for flattish 2015
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 4:08PM CST

EXL: 14.35 (+0.23)

Excel Trust declares $0.18 dividend
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 3:57PM CST

EXL: 14.35 (+0.23)

Excel Trust beats by $0.03, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 3:39PM CST

EXL: 14.35 (+0.23)

Excel Trust Announces Fourth Quarter and Year Ended 2014 Results, Increases Dividend
Marketwired - Wed Feb 11, 3:35PM CST
Excel Trust, Inc. (NYSE: EXL) announced today financial and operating results for the quarter and year ended December 31, 2014. A supplemental financial package with additional information can be found on Excel Trust's website under the Investor Relations tab.
EXL: 14.35 (+0.23)

Notable earnings after Wednesday's close
Seeking Alpha - at Seeking Alpha - Tue Feb 10, 4:35PM CST

TSLA: 198.08 (+2.43), ITRI: 37.00 (+0.66), PNRA: 161.67 (+0.75), SKX: 71.41 (-0.55), STMP: 58.68 (-0.14), ZEN: 22.17 (-1.24), SLF: 32.53 (+1.14), FET: 19.28 (+0.41), HOS: 19.66 (+0.39), HIVE: 4.49 (-0.01), AEM: 29.72 (+1.16), CAKE: 49.11 (+0.29), AMAT: 24.12 (+0.04), CSCO: 28.44 (+0.18), WFM: 53.97 (+0.35), CJES: 11.08 (+0.23), HNI: 53.85 (+1.02), IO: 2.27 (+0.05), GAS: 50.15 (+0.77), QDEL: 25.63 (-0.36), CSOD: 29.09 (-0.20), EXL: 14.35 (+0.23), NVDA: 23.47 (+0.25), DDR: 19.33 (+0.43), NTWK: 5.80 (-0.30), AMBR: 9.23 (+0.30), CPA: 104.64 (+0.68), FORR: 36.60 (-0.28), AUY: 3.91 (+0.20), CTL: 35.30 (+0.44), ACHC: 72.77 (+1.17), OII: 52.53 (-0.31), NU: 52.54 (+1.31), CVA: 22.83 (+0.52), PPC: 26.84 (-0.10), REG: 69.90 (+2.17), TAL: 42.18 (+0.78), SWM: 46.05 (+0.88), Z: 107.15 (-1.82), FEYE: 41.69 (-1.33), ABCO: 52.92 (+0.41), TCX: 19.01 (-0.07), DIOD: 30.23 (+0.49), MET: 51.62 (+1.01), SPRT: 1.68 (+0.06), TRIP: 86.35 (+2.55), CYS: 8.97 (+0.02), NSIT: 28.48 (+0.60), TTGT: 12.45 (+0.13), NTAP: 37.32 (+0.62), EFX: 93.08 (+0.29), CRAY: 30.80 (+0.67), LPSN: 11.00 (-0.33), BIDU: 212.69 (-1.88), TSO: 93.51 (+0.42), CXW: 42.10 (+1.18), SCSS: 34.62 (+0.72), EFC: 20.11 (+0.14)

Should You Sell Excel Trust (EXL) Before Earnings? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 7:40AM CST
Excel Trust is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat
EXL: 14.35 (+0.23)

Vectrus: Incentives And Black Swans Make A Compelling Long
Dane Capital Management, LLC - at Seeking Alpha - Sat Jan 31, 4:00AM CST

VEC: 24.98 (-0.15), VSEC: 80.82 (-2.21), ITT: 40.00 (+0.25), ICFI: 42.65 (+1.10), EXL: 14.35 (+0.23), NCIT: 9.70 (-0.11), PNTR: 8.62 (-0.18), XLS: 23.80 (+0.06), EGL: 34.37 (+1.51), SAIC: 55.05 (+1.17), CACI: 89.00 (+1.18), MANT: 34.54 (+1.41), LDOS: 46.26 (+1.18)

Beware Of The Sucker Yield: Bumpy Roads Ahead For Wheeler REIT
Brad Thomas - at Seeking Alpha - Tue Jan 27, 4:59PM CST

ROIC: 18.55 (+0.51), FRT: 149.44 (+3.04), WSR: 16.32 (+0.41), EXL: 14.35 (+0.23), DDR: 19.33 (+0.43), IRC: 10.98 (+0.25), KIM: 27.74 (+0.75), WPG: 17.06 (+0.35), EQY: 27.49 (+0.44), WRI: 37.19 (+0.81), REG: 69.90 (+2.17), RPAI: 16.34 (+0.33), UBA: 23.47 (+0.36), WHLR: 2.63 (-0.08), BRX: 27.01 (+0.64)

3 Income Stocks to Repel Volatility in 2015 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 26, 9:15AM CST
Should auld troubles be forgot, then the beginning of this New Year would have truly been a happy one. But there seems no respite from volatility.
GMLP: 26.94 (+0.60), AHGP: 52.37 (+2.05), EXL: 14.35 (+0.23)

Ventas (VTR) Scales New 52-Week High on Closing Acquisition - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 23, 1:51PM CST
Shares of Ventas Inc. (VTR) scaled a new 52-week high of $ 80.06 at the end of the trading session on Jan 22.
GGP: 31.00 (+0.42), BXP: 144.73 (+3.58), EXL: 14.35 (+0.23), VTR: 73.73 (+1.87)

Excel Trust Announces Tax Treatment of 2014 Dividend Distributions
Marketwired - Tue Jan 20, 6:02PM CST
Excel Trust, Inc. (NYSE: EXL), a retail focused real estate investment trust (REIT), announced today the tax treatment of its 2014 dividend distributions.
EXL: 14.35 (+0.23)

NYSE stocks posting largest volume increases
AP - Thu Jan 15, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
PACD: 3.98 (+0.26), FCE.A: 25.54 (+0.34), AF: 13.03 (+0.16), ARES: 18.27 (+0.17), BBY: 40.79 (-0.81), FDO: 79.90 (+0.20), GCAP: 9.75 (+0.08), EXL: 14.35 (+0.23), HPP: 33.62 (+1.28), SWN: 22.60 (+0.33), ANFI: 9.66 (-0.15)

Excel Trust Announces Fourth Quarter and Year-End 2014 Earnings Release Date and Conference Call Information
Marketwired - Thu Jan 15, 4:38PM CST
Excel Trust, Inc. (NYSE: EXL), a retail focused real estate investment trust (REIT), announced today that its fourth quarter and year-end 2014 earnings will be released after the market closes on Wednesday, February 11, 2015. Senior Management will host a conference call the following day, Thursday, February 12, 2015 at 1:00 p.m. Eastern Time.
EXL: 14.35 (+0.23)

Mall REIT sector upgraded at Wells Fargo
Seeking Alpha - at Seeking Alpha - Wed Jan 14, 6:39AM CST

PEI: 23.75 (+0.80), GGP: 31.00 (+0.42), EQY: 27.49 (+0.44), SPG: 197.34 (+5.24), WRI: 37.19 (+0.81), REG: 69.90 (+2.17), FRT: 149.44 (+3.04), MAC: 89.21 (-4.29), EXL: 14.35 (+0.23), BRX: 27.01 (+0.64)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Lumexa Imaging's Investor Conference Push: Any Real Substance?

Updated Category News Views 132

Lumexa Imaging just dropped a line on Feb 17, 2026, about their upcoming investor conference gigs. Sure, they're strutting into multiple events—Raymond James in Orlando, Leerink Partners in Miami, and Barclays back-to-back days after that. But here’s the kicker: are these talks really worth the buzz? In a space where outpatient imaging claims to be kingpin, you’ve...

Continue Reading
Current Landscape of US Stock Futures Amid Rate Cuts

Updated Category News Views 173

Insights on the Current Stability of U.S. Stock Futures During Asian trading hours, U.S. stock index futures have held steady. Investors are hoping for interest rate cuts as the Federal Reserve's next meeting approaches. This meeting is expected to reveal a significant easing cycle that many in the market are eagerly anticipating. Even with strong reports on consumer and...

Continue Reading
Wispr Flow Revolutionizes Voice Dictation Across Platforms

Updated Category News Views 469

Wispr Flow Expands Its Reach in Voice Dictation Technology In a world where speed and efficiency are paramount, Wispr, known as The Voice Interface Company, is revolutionizing the way we interact with technology. With the recent launch of Wispr Flow for Windows, this innovative voice productivity tool is now accessible to users across both Mac and Windows platforms,...

Continue Reading
MintMiner: Your Ultimate Gateway to Cloud Mining Success

Updated Category News Views 197

Unlocking the Future of Cloud Mining with MintMiner In today's uncertain financial landscape, MintMiner presents an innovative solution for anyone looking to tap into the world of digital assets. As global financial systems face challenges, MintMiner offers a unique platform that makes cloud mining accessible, straightforward, and profitable. Understanding Cloud Mining...

Continue Reading
GT Biopharma's Strategic Move: Withdrawal of S-1 Registration

Updated Category News Views 100

GT Biopharma's Strategic Withdrawal of Form S-1 Registration GT Biopharma, Inc. (NASDAQ: GTBP) recently made headlines with its request for withdrawal of a Form S-1 registration statement. This decision marks a crucial moment for the company, based in San Francisco, known for its innovative approach in the immuno-oncology sector. GT Biopharma focuses on the development of...

Continue Reading